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Selenocysteine (Sec) is inserted into selenoproteins co-translationally with the help of various cis- and trans-acting factors. The
specific mechanisms of Sec biosynthesis and insertion into protein
in eukaryotic cells, however, are not known. Two proteins, SECp43
and the soluble liver antigen (SLA), were previously reported to
interact with tRNA[Ser]Sec, but their functions remained elusive.
Herein, we report that knockdown of SECp43 in NIH3T3 or
TCMK-1 cells using RNA interference technology resulted in a
reduction in the level of methylation at the 2ⴕ-hydroxylribosyl moiety in the wobble position (Um34) of Sec tRNA[Ser]Sec, and consequently reduced glutathione peroxidase 1 expression. Double
knockdown of SECp43 and SLA resulted in decreased selenoprotein
expression. SECp43 formed a complex with Sec tRNA[Ser]Sec and
SLA, and the targeted removal of one of these proteins affected the
binding of the other to Sec tRNA[Ser]Sec. SECp43 was located primarily in the nucleus, whereas SLA was found in the cytoplasm.
Co-transfection of both proteins resulted in the nuclear translocation of SLA suggesting that SECp43 may also promote shuttling of
SLA and Sec tRNA[Ser]Sec between different cellular compartments.
Taken together, these data establish the role of SECp43 and SLA in
selenoprotein biosynthesis through interaction with tRNA[Ser]Sec in
a multiprotein complex. The data also reveal a role of SECp43 in
regulation of selenoprotein expression by affecting the synthesis of
Um34 on tRNA[Ser]Sec and the intracellular location of SLA.

Several factors required for the specific incorporation of selenocysteine (Sec)2 as the 21st amino acid in the genetic code have been identified, and their roles have been assessed in mammalian cells and tissues
(see Refs. 1 and 2 for reviews). For example, the tRNA that specifically
incorporates Sec into protein in response to Sec UGA codons has been
characterized wherein the amino acid is biosynthesized on the tRNA
following its aminoacylation with serine by seryl-tRNA synthetase (2).
Thus, Sec tRNA has been designated Sec tRNA[Ser]Sec. There are two
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species of this tRNA in mammalian cells that differ by a single methyl
group on the ribosyl moiety at position 34 (designated Um34; Ref. 3).
The form that does not contain Um34 is 5-methoxycarbonylmethyluridine (mcm5U) and that containing Um34 is 5-methoxycarbonylmethyl-2⬘-O-methyluridine (mcm5Um). The two species appear to
have different roles in protein synthesis, wherein mcm5Um is associated
with the synthesis of stress-related selenoproteins (e.g. glutathione peroxidase 1 [GPx1]), and mcm5U is associated with the synthesis of housekeeping selenoproteins (e.g. thioredoxin reductases) (4, 5).
A specialized stem-loop structure in the 3⬘-untranslated region of
mammalian selenoprotein genes, designated the SEC insertion
sequence (SECIS) element, was identified that accounted for UGA
codon specificity in dictating Sec incorporation into protein (6). The
SECIS elements that have been identified in the 24 known selenoproteins in rodents and 25 known selenoproteins in humans (7) fall into two
classes that differ in the occurrence of a ministem that is adjacent to the
apical loop of the structure (8). A SECIS-binding protein, designated
SBP2, was purified from various mammalian sources including liver,
testes, and hepatoma cells (9) and shown to be required along with the
SECIS element in selenoprotein mRNA for Sec insertion into protein
(10). Recently, a ribosomal protein, L30, was found to bind SECIS elements and to have a role in mediating Sec incorporation at the ribosomal level (11). A specific elongation factor for Sec-tRNA[Ser]Sec has
also been characterized (12, 13), and it recognizes only the selenocysteinyl-tRNA[Ser]Sec form of the tRNA and not, for example, the
seryl-tRNA[Ser]Sec form (13). Additional factors that have a role in the
biosynthesis of Sec and its insertion into protein in mammals are selenophosphate synthetases 1 (SPS1; Ref. 14) and 2 (SPS2) (15). These
enzymes apparently are responsible for generating an active form of
selenium for its utilization in Sec synthesis and/or possibly other selenium-requiring reactions. Interestingly, SPS2 is a selenoprotein and
thus has been implicated in the autoregulation of selenoprotein synthesis (15).
There are two other factors that also have been shown to be associated with Sec tRNA[Ser]Sec, SECp43 (16) and the soluble liver antigen,
SLA (17). Protein overlay analysis provided evidence for the interaction
of SECp43 with a 48-kDa protein in HeLa cytoplasmic extracts (16),
whereas SLA was detected in patients with an autoimmune chronic
hepatitis as an autoantibody that precipitated Sec tRNA[Ser]Sec from
human cell extracts and recognized a 48-kDa protein (17). However, the
identity of the 48-kDa protein, the requirements of the SECp43 complex
formation, and the roles of either SECp43 or SLA were not determined.
Herein, we investigated the role of SECp43 and SLA using RNAi
knockdown technology (18 –21). The targeted knockdown of SECp43
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resulted in the reduced formation of Um34 on Sec tRNA[Ser]Sec and
affected selenoprotein expression in a similar manner as mice lacking or
containing reduced levels of mcm5Um (4, 5, 22). These observations
suggest that SECp43 has a role in Um34 synthesis. To target the knockdown of SLA, we generated a construct that contained five knockdown
target sites in SLA mRNA, which resulted in dramatically reduced levels
of this mRNA in transfected cells. Interestingly, transfection of cells
with a construct encoding both SECp43 and SLA knockdown sequences
had a much more pronounced effect on selenoprotein biosynthesis than
either individual knockdown construct suggesting that, although both
components likely have separate roles in selenoprotein synthesis, they
also act in concert. In addition, we found that SLA forms a complex with
SECp43 and Sec tRNA[Ser]Sec and found that SECp43 was located primarily in the nucleus, whereas SLA was in the cytoplasm. However,
co-transfection of both protein genes resulted in the nuclear translocation of the SLA gene product suggesting that the roles of these two
components are interdependent.

EXPERIMENTAL PROCEDURES
Materials—75Selenium (specific activity 1000 Ci/mmol) was purchased from the Research Reactor Facility, University of Missouri,
Columbia, MO, [␣-32P]dCTP (specific activity ⬃6000 Ci/mmol) was
from NEN Corporation, and [3H]serine (specific activity 29 Ci/mmol)
and Hybond Nylon N⫹ membranes were from Amersham. NuPage 10%
polyacrylamide gels, polyvinylidene difluoride membranes, Superscript
II reverse transcriptase, cell culture fetal bovine serum, Dulbecco’s
modified Eagles medium, ␣-minimum essential medium, Lipofectamine 2000, TRIzol reagent, and Hygromycin B were purchased
from Invitrogen. DNA polymerase I large Klenow fragment was
obtained from New England BioLabs, pSilencer 2.0 U6 Hygro vector
was from Ambion, the pTriEx-4 Hygro vector was from Novagen, and
SuperSignal West Dura extended duration substrate was from Pierce.
Anti-His-tag antibodies were purchased from Qiagen, horseradish peroxidase-conjugated secondary antibodies were from Sigma, and SLA
antibodies, generated against the peptide, TFRGFMSHTNNYPC
(amino acids 358 –371 of human SLA), were prepared by Spring Valley
Laboratories, Inc. (Woodbine, MD). pEGFP-N1 and pEGFP-C3 vectors,
green fluorescent protein (GFP) and blue fluorescent protein (BFP)
were purchased from Clontech. A Storm Image system (Molecular
Dynamics) was used to scan Phosphor screens. All other chemicals and
reagents were obtained commercially and were commercial products of
the highest grade available.
Mammalian Cell Lines, Cell Culture, and Transfection—Mouse kidney (TCMK-1) and embryonic fibroblast (NIH3T3) cells were obtained
from ATCC. Chinese hamster ovary AA8 (CHO) cells encoding 10
copies of the wild type mouse Sec tRNA[Ser]Sec transgene were obtained
as given (22). NIH3T3 and TCMK-1 cells were cultured in Dulbecco’s
modified Eagle’s medium, and CHO cells were cultured in ␣-minimum
essential medium, and both media were supplemented with 10% fetal
bovine serum. Transfections were carried out using Lipofectamine 2000
according to the manufacturer’s instructions. Media for cells grown in
the presence of selenium were supplemented with 300 nM sodium
selenite.
Generation of SECp43 Expression and SECp43 and SLA siRNA
Constructs—The SECp43 clone and antibodies to SECp43 were
obtained as given (16). The SECp43 clone was amplified using PCR and
cloned into the pTriEx-4 Hygro vector for SECp43 expression. The
sequence was confirmed by DNA sequencing. The pU6 vector used for
expressing siRNA constructs was constructed using the pSilencer
2.1-U6 Hygro vector as the backbone. Changes were inserted into the
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vector as follows: 1) GC (positions 468 – 469) were changed to A making
the U6 promoter more homologous to the corresponding wild type
gene, 2) the EcoRI site was deleted at position 4110, and 3) XhoI and
MfeI sites were added at positions 384 and 393, respectively. The latter
two changes made it possible to insert multiple siRNA target sequences
into the vector. The modified vector was designated as pU6-m4 Hygro.
For knocking down SECp43 gene expression, five separate 19-nt
sequences, 5⬘-TTATCCGAAACCGCCTCAC-3, 5⬘-GCCGAGAAGTGTTTGCATA-3⬘, 5⬘-TTGTGAAATTCACAGATGA-3⬘, 5⬘-GCAGTACCAGAACTACTAT-3⬘, and 5⬘-CCATGCAGACATATGAAGA3⬘, were selected from within mouse SECp43 cDNA as being unique to
this gene using the online service “siDESIGN” of Dharmacon Research,
Inc. Oligonucleotides containing 19 nt of sense and 19 nt of complementary (antisense) sequences with an intervening AGAGAACTT loop
were synthesized and inserted into the pU6-m4 Hygro vector according
to the manufacture’s instructions. The sequences of all five of SECp43
siRNA constructs were verified by sequencing. The five constructs and
the negative control plasmids were separately transfected into NIH3T3
and TCMK-1 cells. After stabilizing the transfected cells with 0.8 mg/ml
hygromycin, several colonies were selected from plates, and the SECp43
mRNA levels were determined by northern hybridization as described
below. Based on mRNA levels, the best siRNA target sequence was
identified as 5⬘-GCAGTACCAGAACTACTAT-3⬘, and its siRNA construct was used in subsequent experiments.
For knocking down mouse SLA (designated MSLA) gene expression,
five separate 19 –24-nt sequences, 1) 5⬘-GCTTGCAGTCATGGATAGCAACAA-3, 2) 5⬘-GAAATATCACCGGATCGTCCAA-3⬘, 3)
5⬘-GCTCATCACCTTCCAATACGT-3⬘, 4) 5⬘-GTCAACAACGCTTATGGATTA-3⬘, and 5) 5⬘-GAACAGACTAGAGCAAGTG-3⬘, were
selected from within MSLA cDNA as being unique to this gene using
the online service siDESIGN of Dharmacon Research, Inc. Oligonucleotides containing between 19 and 24 nt of sense and 19 to 24 nt of complementary (antisense) sequences with an intervening AGAGAACUU
loop were synthesized and inserted separately within the BamHI and
HindIII cloning sites of the pU6-m4 Hygro vector. The sequences of all
five of MSLA siRNA constructs were determined for confirmation. For
combining the five siRNA transcription units, two of the constructs
(encoding the second and fourth siRNA sequences shown above) were
digested with EcoRI and XhoI to release the U6-siRNA units. Two additional constructs (encoding the first and third siRNA sequences shown
above) were digested with MfeI and XhoI. The released second and
fourth U6-siRNA unit fragments were purified and inserted separately
into the digested first and third siRNA vectors. Then the first and the
second U6-siRNA units were combined in tandem into one vector,
whereas the third and the fourth U6-siRNA units were combined in
tandem in another vector. Repeating the same procedure, all of the five
U6-siRNA units were inserted into the same vector. The combined
MSLA construct and the negative control plasmids were transfected
into NIH3T3 and TCMK-1 cells. After stabilizing the transfected cells
with 0.8 mg/ml hygromycin, MSLA mRNA levels were determined by
northern blot hybridization as described below.
To generate a double knockdown vector encoding the siRNA targeting site for SECp43 mRNA and the five targeting sites for MSLA, the
MSLA siRNA construct was digested with EcoRI and XhoI to release the
five MSLAU6-siRNA units as a single fragment. The multiple
MSLAU6-siRNA fragment was then inserted into the SECp43 siRNA
construct, which was initially digested with MfeI and XhoI.
Labeling of Selenoproteins—Cultured cells were washed three times
in phosphate-buffered saline to remove exogenous selenium, suspended
in Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum, 25
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Ci/ml of 75Se added to the medium, and grown an additional 24 h
before harvesting as described (4, 22). Cells were again washed in phosphate-buffered saline, suspended in 1⫻ SDS loading buffer, and electrophoresed on NuPage 10% polyacrylamide gels along with standard
molecular weight markers to assess labeled selenoprotein sizes. The
developed gels were stained with Coomassie Blue, dried, and exposed to
Phosphor screens. The screens were then scanned using a Storm Image
(PhosphorImager) system (4, 22). Band densities of GPx1 were quantified using ImageQuant Version 5.3 (Molecular Dynamics).
Northern Blot Analyses—Total RNA was isolated from various transfected cells using TRIzol reagent. Equal amounts (15 g) from the different cells were loaded onto the gels, and the developed gels were
transblotted onto a nylon membrane. The membrane was hybridized
with 32P-labeled probe and analyzed with a PhosphorImager for northern blot analysis as given (4, 22). The GPx1 probe was prepared and used
as described (4, 22). The SECp43, MSLA, and glyceraldehyde-3-phosphate dehydrogenase probes were generated by either PCR or reverse
transcription-PCR using Superscript II reverse transcriptase and Universal Reference RNA (4, 22). The sizes of all reverse transcription-PCRgenerated probes were in the 500 –1200-bp range. To detect an array of
mRNAs on the same membrane, membranes, after an initial probing for
SECp43 mRNA, were stripped in boiling buffer (0.1⫻ SSC and 0.1%
SDS), hybridized with a second probe, analyzed, stripped, hybridized
with another probe, and analyzed, etc., using successively labeled
MSLA, GPx1, and glyceraldehyde-3-phosphate dehydrogenase cDNA
probes. Hybridized membranes were exposed to Phosphor screens, and
the screens were then scanned using a Strom Image System (Molecular
Dynamics). The density of GPx1 northern blotting bands were quantified using ImageQuant Version 5.2 (Molecular Dynamics).
Immunoprecipitation, Western Blot, and Sec tRNA[Ser]Sec Northern
Blot Analyses—CHO or NIH3T3 cells (1 ⫻ 107) were harvested and
suspended in 1 ml of lysis buffer (1⫻ TBS with 0.2% Triton X-100).
Either 50 l of anti-His-agarose or 5 l of preimmune sera, anti-SLA
sera, or anti-SECp43 antibody along with 50 l of protein A/G-agarose
were added to 500 g of lysis proteins in 1 ml of lysis buffer. After
binding at 4 °C overnight, the agarose beads were washed three times
with 1 ml of 1⫻ TBS with 0.1% Tween 20 and suspended in 30 l of 1⫻
protein loading buffer (for Western blotting) or 1⫻ TBE/urea loading
buffer (for northern blotting). 10 l were loaded onto gels for Western
blotting or for Sec tRNA[Ser]Sec northern hybridization.
Proteins obtained by immunoprecipitation (see above) or from 50 g
of proteins from SECp43 siRNA, MSLA siRNA, or SECp43/MSLA
siRNA-transfected cell lysate and control cell lysate were electrophoresed on NuPage 10% polyacrylamide gels and transferred to polyvinylidene difluoride membranes. Membranes containing proteins obtained
by immunoprecipitation were then incubated with either mouse antiHis (1:2000 dilution), or rabbit-anti-human-SLA (1:250), whereas those
containing cell lysates were incubated with rabbit-anti-mouse GPx1
(1:1000). Horseradish peroxidase-conjugated secondary antibodies
(1:30000) were then applied, and the membranes were washed with
0.1% TBS-T, incubated in SuperSignal West Dura Extended Duration
Substrate, and exposed to x-ray film as given (4, 22). Sec tRNA[Ser]Sec
obtained by immunoprecipitation (see above) was electrophoresed on
15% TBE/urea polyacrylamide gels and transferred to Hybond nylon
membranes, and the membranes were hybridized with 32P-labeled Sec
tRNA[Ser]Sec probe and analyzed with a PhosphorImager as above.
Isolation, Aminoacylation, and Chromatography of tRNA—SECp43
siRNA-transfected and control-transfected NIH3T3 cells were grown
in 75-cm2 plates either with 300 nM SeO32⫺ or without selenium. After
reaching 80 –90% confluence, the cells were collected, and total tRNA
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was isolated from ⬃1 g of cells as described (23). Transfer RNA was
aminoacylated with [3H]serine in the presence of 19 unlabeled amino
acids and rabbit reticulocyte aminoacyl-tRNA synthetases (24), and the
resulting aminoacyl-tRNAs were fractionated on a RPC-5 column (25)
as described (4, 22, 26).
Constructs for Subcellular Localization and Fluorescence Confocal
Microscopy—GFP expression constructs were prepared using
pEGFP-N1 and pEGFP-C3 vectors, respectively. The coding region
of mouse SECp43 was PCR-amplified from NIH3T3 cDNA with forward primer 5⬘-CCTAAGCTTATGGCGGCCAGCCTATGG-3⬘ and
reverse primer 5⬘-GCTGGATCCATCATAGCTGGGATCTCTG-3⬘
and cloned into the HindIII/BamHI sites of pEGFP-N1. To generate
SLA-GFP expression construct, the human sequence (accession number NM 153825) was PCR-amplified from HEK-293 cDNA with forward primer 5⬘-CCTGAATTCATGGACAGCAACAATTTC-3⬘ and
reverse primer 5⬘-TCGGTCGACCCTGAAGAAGCATCCTGGTATGTG-3⬘ (underlined, italicized sequences specific endonuclease restriction sites) and cloned into the EcoRI/SalI sites of pEGFP-N1. The
human sequence (designated HSLA) was chosen because it shares 86.9%
identity with its predicted mouse homolog (27). In addition, C-terminal
GFP fusion proteins were generated, correspondingly, using vector
pEGFP-C3 for comparison. To study the co-localization of SECp43 and
HSLA, the GFP sequence of SECp43-GFP was cut with BamHI/HpaI
and replaced with BFP to generate a SECp43-BFP fusion protein. For
fluorescence confocal microscopy, images were collected using an
Olympus FluoView 500 laser scanning microscope (Melville, NY).

RESULTS
Development of Multi-siRNA Constructs for Efficient Knockdown of
SECp43 and MSLA mRNA Expression—Because SECp43 (16) and
MSLA (17) were previously implicated in binding Sec tRNA[Ser]Sec, we
explored the possibility of whether these two proteins function in the
same pathway, or possibly in concert, by knocking down their gene
expression using RNAi technology. Constructs of the five 19-nt
sequences selected for targeting knockdown of mouse SECp43 (see
“Experimental Procedures”) were examined for their ability to reduce
the mRNA level of this protein in NIH3T3 cells. The construct corresponding to nucleotides 594 – 612 within the coding sequence was the
most effective of those examined and was sufficient for targeting the
removal of SECp43 mRNA (comparative data not shown). This siRNA
construct, which is designated SECp43 siRNA construct, was used in all
subsequent experiments.
When five distinct MSLA siRNA targets were assayed individually for
their knockdown potential, they were unsuccessful in reducing mRNA
levels more than 50 – 60% (data not shown). Therefore, we generated a
construct that encoded all five of the RNAi sequences unique to the
corresponding cDNA as described under “Experimental Procedures.”
Finally, we devised a strategy to knockdown both proteins in the same
cell line. The SECp43 siRNA target sequence was cloned into the multisiRNA vector-construct developed in targeting MSLA knockdown such
that the new construct contained the five MSLA targeting sequences
and the SECp43 targeting sequence. This construct was designated
SECp43/MSLA siRNA construct.
SECp43 and MSLA siRNAs Target Their Respective mRNAs for
Removal—Northern blot analysis was used to document the effect of
the SECp43 and MSLA siRNA on inhibiting the expression of the corresponding target mRNAs following transfection of NIH3T3 and
TCMK-1 cells with the appropriate construct. TCMK-1 cells were
transfected with either the SECp43 siRNA construct or the MSLA
siRNA construct (Fig. 1A), and NIH3T3 cells were transfected with
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FIGURE 1. Assessment of SECp43 and MSLA mRNA levels in the corresponding
siRNA knockdown cells by northern blotting. A, TCMK-1 cells were transfected with
the SECp43 siRNA construct (lanes 1 and 2), the MSLA siRNA construct (lanes 3 and 4), or
the control vector (lanes 5 and 6) and grown in the presence (lanes 2, 4, and 6) or absence
of supplemental selenium (lanes 1, 3, and 5). B, NIH3T3 cells were transfected with the
SECp43 siRNA construct (lanes 1 and 2), the MSLA siRNA construct (lanes 3 and 4), the
SECp43/MSLA siRNA construct (lanes 5 and 6), or the control vector (lanes 7 and 8) and
grown in the presence (lanes 2, 4, 6, and 8) or absence of supplemental selenium (lanes 1,
3, 5, and 7). Total RNA was extracted for northern blotting and hybridized with the appropriate 32P-labeled cDNA probes as described under “Experimental Procedures.” Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA was used as a control to monitor
sample loading.

either of these siRNA constructs or the SECp43/MSLA siRNA con[Ser]Sec
struct (Fig. 1B). Because selenoproteins and Sec tRNAmcm5Um
are
responsive to selenium status (2, 4) and because the two protein factors
were implicated in selenoprotein metabolism (16, 17), the effects of the
siRNA constructs on the targeted mRNAs were examined in cells grown
in the presence or absence of supplemental selenium. SECp43 siRNA
effectively knocked down its mRNA in both NIH3T3 and TCMK-1 cells
when the cells were grown either in the absence (compare lanes 1 and 5
in Fig. 1A with lanes 1 and 7 in Fig. 1B, respectively) or the presence of
supplemental selenium (compare lanes 2 and 6 in Fig. 1A with lanes 2
and 8 in Fig. 1B, respectively). MSLA RNAi also inhibited the expression
of its mRNA in NIH3T3 and TCMK-1 cells transfected with the multisiRNA construct grown in the absence (compare lanes 3 and 5 in Fig. 1A
with lanes 3 and 7 in Fig. 1B, respectively) or presence of supplemental
selenium (compare lanes 4 and 6 in Fig. 1A with lanes 4 and 8 in Fig. 1B,
respectively). As expected, the SECp43/MSLA siRNA was also effective
in knocking down both targeted mRNAs in NIH3T3 cells, independent
of selenium status (compare lanes 5 and 7 with 6 and 8 in Fig. 1B).
SECp43 and MSLA siRNA Effects on Selenoprotein Expression,
75
Se-labeling—A simple means of monitoring selenoprotein synthesis is
to label the respective treated and untreated cells with 75Se and resolve
the labeled proteins by gel electrophoresis. To examine the effect of the
siRNA knockdown constructs on selenoprotein expression, NIH3T3
cells were stably transfected with the SECp43 siRNA, MSLA siRNA, and
SECp43/MSLA siRNA constructs or the control vector, and the cells
were grown in the presence and absence of supplemental selenium and
labeled with 75Se (Fig. 2). The upper panel in Fig. 2A shows the labeling
of selenoproteins, whereas the lower panel shows the Coomassie Bluestained gel from the transfected cells following gel electrophoresis.
Clearly, the double knockdown SECp43/MSLA siRNA construct had a
greater effect on selenoprotein synthesis than either of the individual
siRNA knockdown constructs (compare lanes 5 and 6 (double knockdown construct) with lanes 1– 4 (SECp43 and MSLA siRNA constructs,
respectively) and lanes 7 and 8 (control construct)). MSLA siRNA did
not appear to affect selenoprotein synthesis (compare lanes 3 and 4 with
lanes 7 and 8), but SECp43 siRNA appeared to selectively reduce the
amount of GPx1 when the cells were grown in the presence of supplemental selenium (compare lanes 2 and 8). The relative intensities of the
GPx1 bands were quantified to examine more closely the effect of
SECp43 knockdown on GPx1 expression (Fig. 2B). The level of GPx1 in
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FIGURE 2. 75Se-Labeling of SECp43 siRNA knockdown cells. NIH3T3 cells were transfected with the SECp43 siRNA construct (lanes 1 and 2), the MSLA siRNA construct (lanes
3 and 4), the SECp43/MSLA siRNA construct (lanes 5 and 6), or the control vector (lanes 7
and 8), grown in the presence (lanes 2, 4, 6, and 8) or absence of supplemental selenium
(lanes 1, 3, 5, and 7), and then labeled overnight with 75Se. Cell lysates were run on gels,
and the gels were stained with Coomassie Blue(lower panel), dried, and exposed to a
PhosphorImager screen (upper panel) as described under “Experimental Procedures.”
The average densities of GPx1 bands from three separate labelings are shown in B. The
asterisk (*) indicates a p value equal to or lower than 0.01.

cells transfected with the SECp43 siRNA construct was significantly
reduced in cells grown in the presence of selenium (p value was 0.01, see
legend to Fig. 2).
SECp43 siRNA Effects on GPx1 Expression, Northern and Western
Blot Analyses—To further assess the effect of SECp43 siRNA on GPx1
expression, NIH3T3 cells transfected with either the SECp43 siRNA
construct or control vector were examined for GPx1 mRNA expression
by northern blot analysis (Fig. 3A) and for GPx1 expression by Western
blot analysis (Fig. 3C). In addition, we examined the effects of MSLA and
SECp43/MSLA siRNA on the expression of GPx1 mRNA and the protein itself. SECp43 siRNA reduced GPx1 mRNA expression in both
TCMK-1 and NIH3T3 cells when the cells were grown in the presence
or absence of selenium (Fig. 3A, compare lanes 2 and 8 with lanes 1 and
7, respectively), whereas MSLA siRNA did not reduce GPx1 mRNA
expression (see lanes 3, 4, 7, and 8). The double knockdown construct,
SECp43/MSLA siRNA, had a dramatic effect on GPx1 mRNA expression in NIH3T3 cells, especially in the presence of selenium (Fig. 3A,
compare lanes 6 and 8). To better illustrate the effects of the SECp43
siRNA and the double knockdown constructs on GPx1 mRNA and
GPx1 expressions, the relative amounts of these components in cells
transfected with the different constructs were quantified (Fig. 3B). The
most pronounced effects on GPx1 mRNA and protein reductions
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FIGURE 3. Assessment of GPx1 mRNA and protein levels by northern and Western blotting in
extracts of SECp43, MSLA, and SECp43/MSLA
siRNA knockdown cells. A, in the top two rectangular boxes, TCMK-1 cells were transfected with
the SECp43 siRNA construct (lanes 1 and 2), the
MSLA siRNA construct (lanes 3 and 4) or with the
control vector (lanes 7 and 8), and the cells were
grown in the presence (lanes 2, 4, and 8) or absence
(lanes 1, 3, and 7) of supplemental selenium.
TCMK-1 cells were not transfected with the
SECp43/MSLA siRNA construct. NIH3T3 cells were
transfected with the SECp43 siRNA construct
(lanes 1 and 2), the MSLA siRNA construct (lanes 3
and 4), the SECp43/MSLA siRNA construct (lanes 5
and 6), or the control vector (lanes 7 and 8) and
grown in the presence (lanes 2, 4, 6, and 8) or
absence of supplemental selenium (lanes 1, 3, 5,
and 7), and extracts were prepared for northern (A,
lower two long rectangular boxes) or Western blotting (C) as described under “Experimental Procedures.” Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used in northern blots in A,
and tubulin was used in B as the controls to monitor sample loading. The densities of GPx1 bands
from northern blotting of TCMK-1 cell RNA are
shown in the upper panel of B, and the average
densities of GPx1 bands from three separate
northern blottings of NIH3T3 cell RNA are shown
in the lower panel of B. The asterisk (*) indicates a p
value equal to or lower than 0.01 in each case with
the exception of that in lane 5, which is 0.03.

occurred in the presence of the double knockdown construct. In addition, the SECp43 siRNA construct caused a significant reduction in
GPx1 mRNA that was more apparent in the TCMK-1 than NIH3T3
cells.
As expected, Western blot analysis of GPx1 in extracts of the various
siRNA knockdown cells (Fig. 3C) yielded similar results as that observed
for GPx1 mRNA. It should also be noted that GPx1 mRNA is thought to
be subject to nonsense-mediated decay in cells and tissues that are deficient in selenium, which also lack or have lower levels of Sec
[Ser]Sec
tRNAmcm5Um
(see Refs. 4 and 5 and references therein). Therefore, the
reduced amounts of GPx1 mRNA observed by northern analysis and
GPx1 observed by Western analysis in cells grown in the absence of
selenium (Fig. 3) were anticipated.
SECp43 siRNA Effects on Um34 Synthesis—Because NIH3T3 cells
had reduced levels of GPx1 in SECp43 siRNA-transfected cells than
control cells (see above), and this effect is also a characteristic of mammalian cells and tissues containing lower amounts of the mcm5Um
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isoform (4, 5), we examined the Sec tRNA[Ser]Sec population in NIH3T3
cells transfected with SECp43 siRNA or the control vector. Total tRNA
was isolated from both transfected cells lines that were grown in the
presence and absence of supplemental selenium and the tRNA was aminoacylated with [3H]serine. The resulting [3H]seryl-tRNA was chro[Ser]Sec
matographed on a RPC-5 column to separate [3H]seryl-tRNAmcm5U
[Ser]Sec
3
and [ H]seryl-tRNAmcm5Um (Fig. 4, A and B). The tRNA species lacking
Um34 (mcm5U) eluted earlier from the column than the form containing Um34 (mcm5Um) (4, 22). Comparison of the distributions of the
two species in transfected cell lines grown in the presence of supplemented selenium showed that there was more mcm5U than mcm5Um
in the cells containing SECp43 siRNA, whereas the reverse was evident
in cells transfected with the control vector (Fig. 4, A1 and B1, respectively). As the distribution of the two Sec tRNA[Ser]Sec species is known
to be responsive to selenium status (2, 4, 5, 22), the proportion of
mcm5Um was reduced substantially in the control cell line, as expected,
when grown in the absence of supplemental selenium as compared with
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that grown in the presence of added selenium (compare Fig. 4, B1 and
B2 and see Refs. 2, 4, and 22). The level of mcm5Um was even more
reduced in cells containing the SECp43 siRNA construct and grown in
the absence of supplemental selenium (compare A2 to A1 and to B2)
further demonstrating the effect of SECp43 on Um34 synthesis.
Cellular Interrelationship of SECp43 and SLA, Co-precipitation—To
examine the cellular interrelationship of SECp43 and SLA, CHO cells
were transfected with the SECp43 expression construct encoding a Histag at the C terminus of the protein, and the resulting cell extracts were
treated with SLA or His-tag antibodies (Fig. 5A). Extracts from CHO

FIGURE 4. Effect of SECp43 siRNA on Sec tRNA[Ser]Sec Um34 synthesis. Total tRNA was
isolated from NIH3T3 cells and aminoacylated with [3H]serine, and the resulting
[3H]seryl-tRNA was chromatographed on a RPC-5 column as given under “Experimental
Procedures”. [3H]Seryl-tRNA[Ser]Sec from cells were transfected with the SECp43 siRNA
construct (A panels) or with the control vector (B panels) and grown in the presence
(designated ⫹Se) or absence of supplemental selenium (designated ⫺Se) as shown.
Variations in elution positions of the two tRNA[Ser]Sec isoforms shown in the figure are a
reflection of the use of slightly different NaCl gradients in the different runs.

cells transfected with the SECp43 expression construct that were
immunoprecipitated with anti-His-tag (to bring down SECp43), yielded
a strong signal on Western blots using antibodies against SLA (see Fig.
5A, lane 2). Extracts from CHO cells transfected with the control protein expression construct encoding a His-tag at its C terminus did not
respond on Western blots (Fig. 5A, lane 1). Immunoprecipitation with
anti-SLA antibodies further confirmed the presence of the in vivo
SECp43-MSLA complex (Fig. 5A, lane 4). Interestingly, similar results
were obtained on northern blots by assaying for the attachment of Sec
tRNA[Ser]Sec to the SECp43-SLA complex in NIH3T3 cell extracts transfected with either the SECp43 siRNA or MSLA siRNA construct or the
control vector (Fig. 5B). Immunoprecipitation of SECp43 from extracts
of NIH3T3 cells transfected with either the SECp43 or MSLA siRNA
constructs pulled down very little Sec tRNA[Ser]Sec compared with that
observed with the control (compare lanes 1 and 2 with lane 3 in the left
panel of Fig. 5B). Immunoprecipitation of MSLA from extracts of
NIH3T3 cells transfected with either the SECp43 or MSLA siRNA constructs manifested reduced pull down of Sec tRNA[Ser]Sec compared
with that observed with the control (compare lanes 4 and 5 with lane 6
in right panel of Fig. 5B). However, less Sec tRNA[Ser]Sec pull down
occurred with the MSLA knockdown cells compared with SECp43
knockdown cells (Fig. 5B, compare lanes 4 and 6 with lanes 5 and 6,
respectively). Clearly, the targeted removal of either one of these factors
affected the binding of Sec tRNA[Ser]Sec to the complex, although
tRNA[Ser]Sec binding appears to be far more stringently dependent on
SLA.
Cellular Interrelationship of SECp43 and SLA, Subcellular
Localization—To investigate the cellular distribution of SECp43, both
N- and C-terminal GFP fusion constructs were generated. SECp43-GFP
was predominantly present in the nucleus of NIH3T3 cells 48 h after
transfection (Fig. 6). Because N- or C-terminal GFP fusion might affect
localization, a GFP-SECp43 construct was also tested that confirmed
the subcellular localization of SECp43 as being in the nucleus (data not
shown).
We also investigated the cellular location of SLA and used the corresponding HSLA as the model protein. For this purpose, HSLA䡠GFP
fusion constructs were generated. Transfection experiments revealed
the cytosolic accumulation of SLA䡠GFP, whereas GFP expression alone
resulted in the homogenous nuclear and cytosolic distribution (Fig. 6).

FIGURE 5. Immunoprecipitation (IP) of SECp43
and MSLA. A, lysates of CHO cells transfected with
the SECp43 expression construct (lanes 2– 4) or the
vector encoding the His-tag control protein (lane
1) were mixed with anti-His antibody (lanes 1 and
2), anti-SLA sera (lane 4), or preimmune sera (lane
3). The mixture was run on gels, the gels were
transblotted onto membranes, and Western blots
were prepared as described under “Experimental
Procedures.” B, lysates of extracts of NIH3T3 cells
transfected with the SECp43 siRNA or MSLA siRNA
constructs or the control vector were mixed with
either anti-SECp43 antibody (lanes 1–3) or antiSLA sera (lanes 4 – 6). The mixture was run on gels,
the gels were transblotted, and northern blots
were prepared by hybridizing with 32P-labeled Sec
tRNA[Ser]Sec cDNA as described under “Experimental Procedures.”
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FIGURE 6. Localization of SECp43 and HSLA. Confocal images of NIH3T3 cells expressing GFP-fused SECp43, HSLA, and GFP control protein at 48 h posttransfection after a
single transfection are illustrated as follows. A set of three images is shown for each
construct. Left panels, green fluorescence corresponding to transiently expressed fusion
proteins; center panels, fluorescence of the fusion proteins merged with the phase contrast; and right panels, images obtained by using phase contrast. GFP-transfected cells
were photographed at 20⫻ magnification, and SECp43-GFP- and HSLA-GFP-transfected
cells were photographed at 40⫻ magnification.

The same result was obtained using a GFP䡠HSLA fusion construct (data
not shown).
Because the co-immunoprecipitation studies with SECp43 and
MSLA revealed that they formed a complex, we examined the co-transfection of the SECp43-BFP fusion and the HSLA-GFP fusion proteins to
assess their subcellular co-localization. As shown in Fig. 7, after cotransfecting NIH3T3 cells with the corresponding fusion protein constructs, HSLA appeared in the nucleus. As SLA does not have an obvious nuclear localization signal or phosphorylation sites that might
govern its transfer to the nucleus, this finding suggested that SECp43
may act as a chaperone for SLA directing its subcellular localization.
These observations are further considered below in the Discussion.

DISCUSSION
When both SECp43 (16) and SLA (17) were discovered, they were
characterized as RNA-binding proteins that formed a complex with Sec
tRNA[Ser]Sec. SECp43 was also found to have two RNA binding sites and
to interact with a 48-kDa protein. The 48-kDa component, however,
was not identified (16). In a separate study, a 48-kDa protein was precipitated in a complex with an autoantibody in human cell extracts that
was found in patients with autoimmune chronic hepatitis (17). It is
apparent from the present study that the SECp43-associated protein
was most likely SLA as MSLA is a 48-kDa protein, and it was found
herein to exist in a complex with SECp43 in NIH3T3 cells. Interestingly,
Sec tRNA[Ser]Sec was also shown to occur in this complex providing strong
evidence that the multifarious complex includes all three components.
More importantly, our study provided the first evidence for the role of
SECp43 and SLA in regulation of selenoprotein expression and firmly
linked these proteins to the pathway of selenoprotein biosynthesis.
Different approaches were employed to elucidate the function of the
two protein components in the complex. Initially, we used RNAi technology to knockdown SECp43 mRNA and devised a siRNA vector
encoding five separate targeting sites in MSLA mRNA to effectively
reduce its level. Under our cell culture conditions, knockdown of

41574 JOURNAL OF BIOLOGICAL CHEMISTRY

FIGURE 7. Co-transfection and localization of SECp43 and HSLA. Confocal images of
NIH3T3 cells co-transfected with SEC43-BFP and HSLA-GFP photographed 48 h posttransfection are shown as follows. I, SECp43-BFP (A), HSLA-GFP (B), merged blue and
green signals (C), and merged signals including phase contrast (D) (40⫻ magnification);
II, SECp43-BFP (A), HSLA-GFP (B), merged signals of BFP and GFP (C) (60⫻ magnification).

SECp43 mRNA had no effect on MSLA mRNA expression, and the
knockdown of MSLA mRNA had no effect on SECp43 expression in
either NIH3T3 or TCMK-1 cells. Although the virtual removal of
MSLA mRNA had no detectable effect on selenoprotein expression,
knockdown of SECp43 mRNA affected GPx1 mRNA and protein
expression levels. Because these observations regarding GPx1 mimic
those observed in mammalian cells and tissues containing reduced levels of the mcm5Um isoform (4, 5), we examined the effect of SECp43
knockdown on the distribution of mcm5U and mcm5Um in NIH3T3
cells. The level of mcm5Um relative to mcm5U was reduced in cells
transfected with the SECp43 siRNA construct compared with cells
transfected with the control vector. These studies provide evidence that
SECp43 is involved in Um34 methylation. Whether this is a transient
effect on Um34 synthesis or a direct effect that is responsible for Um34
formation must await further study. However, additional studies on
SECp43 described herein clearly show that it has other roles than an
involvement in methylation of Sec tRNA[Ser]Sec at position 34 (see
below).
Interestingly, simultaneous knockdown of SECp43 and MSLA
mRNAs reduced the overall expression of selenoproteins suggesting
that the two protein factors act in concert. The two factors do indeed
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form a complex with Sec tRNA[Ser]Sec, and the targeted reduction of
either one of the factors substantially reduced the overall binding of
tRNA to the complex. The cellular location of SECp43 suggests additional roles of this factor. For example, SECp43 occurs primarily in the
nucleus; however, when the construct encoding it was co-transfected
with that of SLA, it resulted in the nuclear translocation of SLA from the
cytoplasm to the nucleus. This observation suggests that SECp43 may
function as a chaperone for SLA and Sec-tRNA[Ser]Sec. Although the
present study provides new insights into the roles of SECp43 and SLA
and firmly plants them as important factors in the biosynthesis of Sec
and its incorporation into protein, the full characterization of these two
factors must await further studies.
Sec insertion in bacteria has been thoroughly characterized and all
involved factors identified (28). The bacterial pathway includes an elongation factor (SelB), Sec synthase (SelA), Sec tRNA (SelC), and selenophosphate synthetase (SelD). Conservation of some of these components suggested that a similar mechanism operates in eukaryotes,
including mammals. However, recent studies clearly changed this paradigm as several additional factors have been identified (1, 2). The present study has demonstrated the significance of two additional factors,
SECp43 and SLA, in this pathway that are not present in bacteria. These
observations highlight an increasing complexity of the Sec insertion
machinery during evolution.
In conclusion, this study provides the first evidence for the direct role
of SECp43 and SLA in selenoprotein biosynthesis. These factors interact and occur in a complex with tRNA[Ser]Sec. In addition, our study
linked SECp43 to the regulation of selenoprotein synthesis through its
involvement in methylation of tRNA[Ser]Sec and the intracellular distribution of SLA.
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